Shattuck Labs (STTK) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $5.42, -1.99% vs the prior close of $5.53.
- Volume 648.46K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
STTK dips 2.0% to $5.42. Closed at $5.42, -1.99% vs the prior close of $5.53. Day range $5.27–$5.54, opened at $5.53.
STTK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — STTK dips 2.0% to $5.42
- Closed at $5.42, -1.99% vs the prior close of $5.53. Day range $5.27–$5.54, opened at $5.53.
- Volume was 648.46K shares, 0.5x its 50-day average of 1.20M — lighter than usual.
- Price is -18.2% vs its 50-day average ($6.63) and -9.2% vs its 200-day average ($5.97).
- 52-week range $1.72–$8.33; today's close sits at 56% of that range, 34.9% below the 52-week high.
Oct 15, 2026 — STTK jumps 3.8% to $5.53
- Closed at $5.53, +3.75% vs the prior close of $5.33. Day range $5.30–$5.59, opened at $5.35.
- Volume was 867.80K shares, 0.7x its 50-day average of 1.20M.
- Price is -17.0% vs its 50-day average ($6.66) and -7.2% vs its 200-day average ($5.96).
- 52-week range $1.70–$8.33; today's close sits at 58% of that range, 33.6% below the 52-week high.
Oct 14, 2026 — STTK dips 2.9% to $5.33, a 3-month low
- Closed at $5.33, -2.91% vs the prior close of $5.49. Day range $5.19–$5.52, opened at $5.32.
- Volume was 1.20M shares, 1.0x its 50-day average of 1.20M.
- Price is -20.5% vs its 50-day average ($6.70) and -10.4% vs its 200-day average ($5.95).
- 52-week range $1.70–$8.33; today's close sits at 55% of that range, 36.0% below the 52-week high.
Oct 13, 2026 — STTK slides 9.9% to $5.49, a 3-month low
- Closed at $5.49, -9.85% vs the prior close of $6.09. Day range $5.47–$6.09, opened at $6.06.
- Volume was 1.58M shares, 1.3x its 50-day average of 1.19M.
- Price is -18.7% vs its 50-day average ($6.75) and -7.6% vs its 200-day average ($5.94).
- 52-week range $1.70–$8.33; today's close sits at 57% of that range, 34.1% below the 52-week high.
Oct 12, 2026 — STTK rises 2.0% to $6.09, 3 up days in a row
- Closed at $6.09, +2.01% vs the prior close of $5.97. Day range $5.85–$6.21, opened at $6.09.
- Volume was 1.02M shares, 0.9x its 50-day average of 1.18M.
- Price is -10.3% vs its 50-day average ($6.79) and +2.7% vs its 200-day average ($5.93).
- 52-week range $1.70–$8.33; today's close sits at 66% of that range, 26.9% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — STTK jumps 5.5% to $5.97
- Closed at $5.97, +5.48% vs the prior close of $5.66. Day range $5.54–$6.02, opened at $5.65.
- Volume was 1.05M shares, 0.9x its 50-day average of 1.18M.
- Price is -12.3% vs its 50-day average ($6.81) and +0.9% vs its 200-day average ($5.92).
- 52-week range $1.70–$8.33; today's close sits at 64% of that range, 28.3% below the 52-week high.
Oct 8, 2026 — STTK ends flat (+0.1%) to $5.66 on 2.2x normal volume
- Closed at $5.66, +0.09% vs the prior close of $5.66. Day range $5.42–$5.89, opened at $5.56.
- Volume was 2.49M shares, 2.2x its 50-day average of 1.14M — unusually heavy trading.
- Price is -17.2% vs its 50-day average ($6.83) and -4.1% vs its 200-day average ($5.90).
- 52-week range $1.70–$8.33; today's close sits at 60% of that range, 32.1% below the 52-week high.
Oct 7, 2026 — STTK slides 3.5% to $5.66, a 3-month low, 4 down days in a row
- Closed at $5.66, -3.50% vs the prior close of $5.86. Day range $5.55–$5.82, opened at $5.76.
- Volume was 1.11M shares, 1.0x its 50-day average of 1.13M.
- Price is -17.5% vs its 50-day average ($6.86) and -4.0% vs its 200-day average ($5.89).
- 52-week range $1.70–$8.33; today's close sits at 60% of that range, 32.1% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — STTK slides 9.8% to $5.86, 3 down days in a row
- Closed at $5.86, -9.85% vs the prior close of $6.50. Day range $5.85–$6.65, opened at $6.55.
- Volume was 1.60M shares, 1.4x its 50-day average of 1.12M.
- Price is -14.8% vs its 50-day average ($6.88) and -0.3% vs its 200-day average ($5.88).
- 52-week range $1.70–$8.33; today's close sits at 63% of that range, 29.7% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — STTK slides 3.4% to $6.50
- Closed at $6.50, -3.42% vs the prior close of $6.73. Day range $6.30–$6.85, opened at $6.73.
- Volume was 1.24M shares, 1.1x its 50-day average of 1.13M.
- Price is -5.8% vs its 50-day average ($6.90) and +10.9% vs its 200-day average ($5.86).
- 52-week range $1.70–$8.33; today's close sits at 72% of that range, 22.0% below the 52-week high.
Oct 2, 2026 — STTK dips 1.6% to $6.73
- Closed at $6.73, -1.61% vs the prior close of $6.84. Day range $6.54–$7.09, opened at $7.02.
- Volume was 1.84M shares, 1.7x its 50-day average of 1.10M.
- Price is -2.8% vs its 50-day average ($6.92) and +15.2% vs its 200-day average ($5.84).
- 52-week range $1.70–$8.33; today's close sits at 76% of that range, 19.2% below the 52-week high.
STTK latest news & SEC filings
Every SEC filing by or about STTK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$15.15M (prior year -$12.46M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year -$0.24) (loss narrowed vs Jun 30, 2025)
Jul 17, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Shukla Abhinav A. sold 410 shares at $7.01 (≈$2.87K) on Jul 2, 2026
- Shukla Abhinav A. sold 410 shares at $7.01 (≈$2.87K) on Jul 2, 2026
- Shukla Abhinav A. sold 410 shares at $7.01 (≈$2.87K) on Jul 2, 2026
- Shukla Abhinav A. sold 410 shares at $7.01 (≈$2.87K) on Jul 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Shukla Abhinav A. sold 100 shares at $7.07 (≈$707) on Jul 1, 2026
- Shukla Abhinav A. sold 100 shares at $7.07 (≈$707) on Jul 1, 2026
- Shukla Abhinav A. sold 100 shares at $7.07 (≈$707) on Jul 1, 2026
- Shukla Abhinav A. sold 100 shares at $7.07 (≈$707) on Jul 1, 2026
- Shukla Abhinav A. sold 23,365 shares at $7.08 (≈$165.42K) on Jun 30, 2026
- Shukla Abhinav A. sold 23,365 shares at $7.08 (≈$165.42K) on Jun 30, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Pandite Arundathy N. sold 30,000 shares at $7.01 (≈$210.30K) on Jun 30, 2026
- Pandite Arundathy N. sold 30,000 shares at $7.01 (≈$210.30K) on Jun 30, 2026
- Pandite Arundathy N. sold 30,000 shares at $7.01 (≈$210.30K) on Jun 30, 2026
- Pandite Arundathy N. sold 30,000 shares at $7.01 (≈$210.30K) on Jun 30, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jun 30, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Things to know before you trade STTK
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 5, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.57% (largest 9.9%). That is a volatile stock.
- Liquidity: about 1.41M shares (≈$7.63M) trade per day on average.
- 52-week position: $5.42 vs a range of $1.72–$8.33 (56% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Abhinav A. Shukla sold 410 shares on Jul 2, 2026.
- Latest filings: 8-K Aug 11, 2026; 10-Q Aug 11, 2026; 8-K Jun 11, 2026.
- Share count: 100.36M shares outstanding (Aug 7, 2026), +109.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
STTK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.53 | 5.54 | 5.27 | 5.42 | 648.46K |
| Oct 15, 2026 | 5.35 | 5.59 | 5.30 | 5.53 | 867.80K |
| Oct 14, 2026 | 5.32 | 5.52 | 5.19 | 5.33 | 1.20M |
| Oct 13, 2026 | 6.06 | 6.09 | 5.47 | 5.49 | 1.58M |
| Oct 12, 2026 | 6.09 | 6.21 | 5.85 | 6.09 | 1.02M |
| Oct 9, 2026 | 5.65 | 6.02 | 5.54 | 5.97 | 1.05M |
| Oct 8, 2026 | 5.56 | 5.89 | 5.42 | 5.66 | 2.49M |
| Oct 7, 2026 | 5.76 | 5.82 | 5.55 | 5.66 | 1.11M |
| Oct 6, 2026 | 6.55 | 6.65 | 5.85 | 5.86 | 1.60M |
| Oct 5, 2026 | 6.73 | 6.85 | 6.30 | 6.50 | 1.24M |
| Oct 2, 2026 | 7.02 | 7.09 | 6.54 | 6.73 | 1.84M |
| Oct 1, 2026 | 6.95 | 7.28 | 6.67 | 6.84 | 2.02M |
| Sep 30, 2026 | 6.64 | 7.42 | 6.52 | 6.82 | 3.36M |
| Sep 29, 2026 | 6.43 | 6.64 | 6.32 | 6.54 | 956.60K |
| Sep 28, 2026 | 6.03 | 6.48 | 5.85 | 6.43 | 976.90K |
| Sep 25, 2026 | 6.33 | 6.39 | 6.05 | 6.07 | 893.70K |
| Sep 24, 2026 | 6.34 | 6.40 | 6.00 | 6.31 | 1.43M |
| Sep 23, 2026 | 6.47 | 6.61 | 6.26 | 6.36 | 1.39M |
| Sep 22, 2026 | 6.20 | 6.54 | 6.10 | 6.50 | 1.46M |
| Sep 21, 2026 | 6.09 | 6.21 | 5.86 | 6.11 | 1.04M |
About Shattuck Labs
Shattuck Labs (STTK) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in AUSTIN, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1680367.
STTK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mona Ashiya | Director | Jun 15, 2026 |
| Daniel G. Baker | Director | Jun 2, 2026 |
| Helen M Boudreau | Director | Jun 2, 2026 |
| Neil W Gibson | Director | Jun 2, 2026 |
| George Golumbeski | Director | Jun 2, 2026 |
| Advisors Llc Orbimed | Director | Jun 15, 2026 |
| Capital Gp Ix Llc Orbimed | Director | Jun 15, 2026 |
| Genesis Gp Llc Orbimed | Director | Jun 15, 2026 |
| Clay B Siegall | Director | Jun 11, 2026 |
| Taylor Schreiber | Chief Executive Officer | May 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Casi Deyoung | Chief Business Officer | Jan 27, 2026 |
| Andrew R Neill | Chief Financial Officer | May 14, 2026 |
| Arundathy N. Pandite | Chief Medical Officer | Jul 2, 2026 |
| Taylor Schreiber | Chief Executive Officer | May 13, 2026 |
| Abhinav A. Shukla | Chief Technical Officer | Jul 7, 2026 |
| Stephen Stout | See Remarks | May 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Abhinav A. Shukla | Sale | 410 | $7.01 |
| Jul 2, 2026 | Abhinav A. Shukla | Sale | 410 | $7.01 |
| Jul 2, 2026 | Abhinav A. Shukla | Sale | 410 | $7.01 |
| Jul 2, 2026 | Abhinav A. Shukla | Sale | 410 | $7.01 |
| Jul 1, 2026 | Abhinav A. Shukla | Sale | 100 | $7.07 |
| Jul 1, 2026 | Abhinav A. Shukla | Sale | 100 | $7.07 |
| Jul 1, 2026 | Abhinav A. Shukla | Sale | 100 | $7.07 |
| Jul 1, 2026 | Abhinav A. Shukla | Sale | 100 | $7.07 |
| Jun 30, 2026 | Abhinav A. Shukla | Sale | 23,365 | $7.08 |
| Jun 30, 2026 | Abhinav A. Shukla | Sale | 23,365 | $7.08 |
| Jun 30, 2026 | Abhinav A. Shukla | Sale | 23,365 | $7.08 |
| Jun 30, 2026 | Abhinav A. Shukla | Sale | 23,365 | $7.08 |
| Jun 30, 2026 | Arundathy N. Pandite | Sale | 30,000 | $7.01 |
| Jun 30, 2026 | Arundathy N. Pandite | Sale | 30,000 | $7.01 |
| Jun 30, 2026 | Arundathy N. Pandite | Sale | 30,000 | $7.01 |
STTK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.00M | $-48.81M | -0.70 | $-39.88M |
| Dec 31, 2024 | $5.72M | $-75.41M | -1.49 | $-60.52M |
| Dec 31, 2023 | $1.66M | $-87.30M | -2.05 | $-81.23M |
| Dec 31, 2022 | $652.00K | $-101.94M | -2.41 | $-94.50M |
| Dec 31, 2021 | $30.02M | $-44.97M | -1.07 | $-57.12M |
Latest balance sheet: total assets $220.67M, total liabilities $9.53M, cash $63.30M (as of Jun 30, 2026).
STTK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $7.18 |
| May 7, 2026 | 8-K Item 2.02 (results) | $6.26 |
| Mar 5, 2026 | 8-K Item 2.02 (results) | $5.10 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $1.96 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $0.86 |
| May 1, 2025 | 8-K Item 2.02 (results) | $1.08 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $1.14 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $1.37 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on STTK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.